Why This Massachusetts Synthetic Bio Startup Could be the Next Biotech Unicorn Post author:Sam Post published:December 11, 2017 Post category:BioPharma In investment jargon, a “unicorn” has at least two meanings. Source: BioSpace You Might Also Like Sanofi's Rumored Buyout Target Flexion Shows Off Mid-Stage Osteoarthritis Data June 11, 2017 Frazier-Backed Mavupharma Scores $20M to Fund STING Program November 28, 2017 Recipharm AB Makes Strategic Appointment In The UK & Ireland May 25, 2017
